Outcomes of multiple salvage chemotherapy for advanced gastric cancer: Implications for clinical practice and trial design

Yong Wha Moon, SunYoung Rha, Hei Cheul Jeung, Chan Kim, Min Hee Hong, Hyun Chang, Jae Kyung Roh, Sung Hoon Noh, Byung Soo Kim, Hyuncheol Chung

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: We analyzed the natural history of advanced gastric cancer with sequential salvage chemotherapy following first-line treatment. Methods: We studied 532 patients with unresectable gastric adenocarcinoma who were treated at Yonsei Cancer Center (2000-2008). The patients were managed with multiple sequential salvage chemotherapy as allowed by performance status and toxicity profiles. The tumor response was assessed every two cycles. Results: Four hundred sixty patients received palliative chemotherapy and 72 received supportive care only. The median overall survival was 12.0 months for all patients, 12.1 months for the chemotherapy group, and 2.5 months for the supportive care group (P <0.001). In the chemotherapy group, 87% received first-line chemotherapy, 47% second-line, 23% third-line, 9% fourth-line, and 3% fifthline. Response rates were 24.8, 12.6, 10.9, 2.6, and 0% and disease control rates were 76.3, 60.1, 54.2, 54.2, and 53.3% for first-to fifth-line treatment, respectively. The median progression-free survival was 5.5, 3.4, 2.5, 1.9, and 2.0 months and overall survival was 12.1, 7.9, 5.5, 5.0, and 6.8 months. Performance status and metastatic pattern were consistent prognostic factors throughout salvage treatment. Conclusions: Clinical trials may be feasible in second-or third-line salvage chemotherapy for gastric cancer. Future clinical trials in these settings should take into account the low response rate, short progression-free survival, and the prognostic factors for optimal trial design.

Original languageEnglish
Pages (from-to)797-805
Number of pages9
JournalCancer Chemotherapy and Pharmacology
Volume66
Issue number4
DOIs
Publication statusPublished - 2010 Sep 1

All Science Journal Classification (ASJC) codes

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Outcomes of multiple salvage chemotherapy for advanced gastric cancer: Implications for clinical practice and trial design'. Together they form a unique fingerprint.

Cite this